Schwartz M - Search Results

1

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.

Llovet JM, Pinyol R, Yarchoan M, Singal AG, Marron TU, Schwartz M, Pikarsky E, Kudo M, Finn RS. Llovet JM, et al. Among authors: schwartz m. Nat Rev Clin Oncol. 2024 Apr;21(4):294-311. doi: 10.1038/s41571-024-00868-0. Epub 2024 Feb 29. Nat Rev Clin Oncol. 2024. PMID: 38424197 Review.

2

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials.

Schwartz JD, Schwartz M, Mandeli J, Sung M. Schwartz JD, et al. Among authors: schwartz m. Lancet Oncol. 2002 Oct;3(10):593-603. doi: 10.1016/s1470-2045(02)00873-2. Lancet Oncol. 2002. PMID: 12372721 Review.

3

Resection and liver transplantation for hepatocellular carcinoma.

Llovet JM, Schwartz M, Mazzaferro V. Llovet JM, et al. Among authors: schwartz m. Semin Liver Dis. 2005;25(2):181-200. doi: 10.1055/s-2005-871198. Semin Liver Dis. 2005. PMID: 15918147 Review.

4

How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

Schwartz M, Roayaie S, Llovet J. Schwartz M, et al. J Hepatol. 2005 Oct;43(4):584-9. doi: 10.1016/j.jhep.2005.07.019. J Hepatol. 2005. PMID: 16120468 Review. No abstract available.

5

Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there.

Llovet JM, Schwartz M, Fuster J, Bruix J. Llovet JM, et al. Among authors: schwartz m. Semin Liver Dis. 2006 Aug;26(3):248-53. doi: 10.1055/s-2006-947296. Semin Liver Dis. 2006. PMID: 16850374

6

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL. Llovet JM, et al. Among authors: schwartz m. Gastroenterology. 2006 Dec;131(6):1758-67. doi: 10.1053/j.gastro.2006.09.014. Epub 2006 Sep 19. Gastroenterology. 2006. PMID: 17087938

7

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.

Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM, Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM, Friedman SL. Kremer-Tal S, et al. Among authors: schwartz m. J Hepatol. 2007 Apr;46(4):645-54. doi: 10.1016/j.jhep.2006.10.012. Epub 2006 Nov 27. J Hepatol. 2007. PMID: 17196295 Free PMC article.

8

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM. Wurmbach E, et al. Among authors: schwartz m. Hepatology. 2007 Apr;45(4):938-47. doi: 10.1002/hep.21622. Hepatology. 2007. PMID: 17393520

9

Strategies for the management of hepatocellular carcinoma.

Schwartz M, Roayaie S, Konstadoulakis M. Schwartz M, et al. Nat Clin Pract Oncol. 2007 Jul;4(7):424-32. doi: 10.1038/ncponc0844. Nat Clin Pract Oncol. 2007. PMID: 17597707 Review.

10

Design and endpoints of clinical trials in hepatocellular carcinoma.

Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials. Llovet JM, et al. Among authors: schwartz m. J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. J Natl Cancer Inst. 2008. PMID: 18477802 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,200 results

Search Page